Insight Molecular Diagnostics (IMDX) Cash from Investing Activities Growth (5y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) Cash from Investing Activities Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 171.73 Mn | 142.80 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.57% |
| Dec 31, 2025 | -24.32% |
| Sep 30, 2025 | -14.83% |
| Jun 30, 2025 | 40.12% |
| Mar 31, 2025 | 45.16% |
| Dec 31, 2024 | 29.62% |
| Sep 30, 2024 | 62.17% |
| Jun 30, 2024 | -76.98% |
| Mar 31, 2024 | -20.21% |
| Sep 30, 2023 | 91.54% |
| Jun 30, 2023 | 55.99% |
| Mar 31, 2023 | -207.38% |
| Dec 31, 2022 | -166.20% |
| Sep 30, 2022 | -95.60% |
| Jun 30, 2022 | -37.11% |
| Mar 31, 2022 | -39.12% |
| Dec 31, 2021 | -30.00% |
| Sep 30, 2021 | -112.94% |
| Jun 30, 2021 | -151.13% |
| Mar 31, 2021 | -253.43% |